Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...
Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy ...
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
Bryan Johnson, the American entrepreneur renowned for his anti-ageing endeavours, has disclosed the details of his latest ...
Medtech giants are doubling down on robotic surgery systems as hospitals see fewer complications and shorter stays.
The Phase II trial comes as the US Food and Drug Administration grants an investigational new drug application for cannabis ...
The group representing medical device makers in Washington is coming out against the Trump administration’s firings of ...
(RTTNews) - Johnson & Johnson (JNJ ... to placebo across all clinical and endoscopic measures consistent with the FDA-approved intravenous induction regimen in this population.
We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to ...